Substituted pyrrolizine compounds and uses thereof
申请人:Gilead Sciences, Inc.
公开号:US10328053B2
公开(公告)日:2019-06-25
This application relates generally to certain substituted pyrrolizine compounds, and pharmaceutical compositions which inhibit HBV replication, and methods of making and using them.